Comparison of Intra-Amniotic (15S)-15-Methyl-PGF2α and Intravaginal Prostaglandin E2 for Second-Trimester Uterine Evacuation

Journal of Perinatology

Volumn 18, Issue 1, 1998, Pages 24-27

  Perry Jr , Kenneth G ^a   Roberts, William E ^a   Martin, Rick W ^a   Magann, Everett F ^a   Sullivan, Davis L ^a   Morrison, John C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; CARBOPROST; PROSTAGLANDIN E2;

AMNION; ARTICLE; COMPARATIVE STUDY; CURETTAGE; FEMALE; HUMAN; INDUCED ABORTION; INJECTION; INTRAVAGINAL DRUG ADMINISTRATION; METHODOLOGY; PREGNANCY; RETAINED PLACENTA; SECOND TRIMESTER PREGNANCY; SUPPOSITORY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; AMNION; CARBOPROST; DILATATION AND CURETTAGE; DINOPROSTONE; FEMALE; HUMANS; INJECTIONS; PLACENTA, RETAINED; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SUPPOSITORIES;

EID: 0031601966     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tietze C. Second trimester abortion: a global view. In: Berger GS, Brenner WE, Keith LG, editors. Second trimester abortion. Boston: John Wright; 1981. p. 1-11.
2. Grimes DA, Schulz KF, Cates WJr, Tyler CW Jr. Mid-trimester abortion by dilatation and evacuation. A safe and practical alternative. N Engl J Med 1977;296:1141-5.
3. Castadot RG. Pregnancy termination: techniques, risks, and complications and their management. Fertil Steril 1986;45:5-17.
4. American College of Obstetricians and Gynecologists. Methods of midtrimester abortion. Washington: American College of Obstetricians and Gynecologists, ACOG Technical Bulletin No. 109, October 1987.
5. 2 versus concentrated oxytocin. Am J Obstet Gynecol 1992;167:1112-6.
6. Hern WM, Zen C, Ferguson KA, Hart V, Haseman MV. Outpatient abortion for fetal anomaly and fetal death from 15-34 menstrual weeks' gestation: techniques and clinical management. Obstet Gynecol 1993;81: 301-6.
7. 2α and termination of middle and late second-trimester pregnancy for genetic indications: a contemporary approach. Am J Obstet Gynecol 1993;169: 332-40.
8. 2 for termination of second-trimester pregnancy. N Engl J Med 1994;331:290-3.
9. 2 suppositories: a randomized trial. Obstet Gynecol 1995;85:699-700.
10. Grimes DA, Cates W Jr. Complications from legally-induced abortion: a review. Obstet Gynecol Surv 1979;34:177-91.
11. Atrash HK, MacKay HT, Binkin NJ, Hogue CJR. Legal abortion mortality in the United States: 1972 to 1982. Am J Obstet Gynecol 1987;156:605-12.
12. 2α for the induction of midtrimester abortion. Am J Obstet Gynecol 1976;125: 821-6.
13. 2α for termination of second-trimester pregnancy: an international multicenter study. Am J Obstet Gynecol 1977;129:601-5.
14. 2α and its 15-methyl derivative for induction of second trimester abortion. Ann Clin Res 1977;9:58-61.
15. Isada NB, Pryde PG, Johnson MP, Hallak M, Blessed WB, Evans MI. Fetal intracardiac potassium chloride injection to avoid the hopeless resuscitation of an abnormal abortus. I. Clinical issues. Obstet Gynecol 1992;80:296-9.